Iradimed (IRMD) Net Cash Flow Growth (1y) (2014 - 2026)
Iradimed (IRMD) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 76.43% |
| 10 | Iradimed | 1.22 Bn | 1.16 Bn | 16.81 Mn | 374.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374.04% |
| Dec 31, 2025 | -1,147.99% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | -21.82% |
| Mar 31, 2025 | 58.95% |
| Dec 31, 2024 | -83.03% |
| Sep 30, 2024 | 245.43% |
| Jun 30, 2024 | 11.91% |
| Mar 31, 2024 | 69.47% |
| Dec 31, 2023 | 27.37% |
| Sep 30, 2023 | -73.15% |
| Jun 30, 2023 | 78.00% |
| Mar 31, 2023 | -31.43% |
| Dec 31, 2022 | -34.71% |
| Sep 30, 2022 | 6.93% |
| Jun 30, 2022 | -60.74% |
| Mar 31, 2022 | -1,676.35% |
| Dec 31, 2021 | 44.02% |
| Sep 30, 2021 | 53.54% |
| Jun 30, 2021 | 430.62% |